Anisha Ambady
AstraZeneca (India)(IN)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Cancer therapeutics and mechanisms, Biochemical and Molecular Research, Antibiotic Resistance in Bacteria, HIV/AIDS drug development and treatment
Most-Cited Works
- → Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo(2013)161 cited
- → Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis(2017)124 cited
- → Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting InhA in Mycobacterium tuberculosis(2013)100 cited
- → 4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity(2014)94 cited
- → Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity(2014)93 cited
- → Lead Optimization of 1,4-Azaindoles as Antimycobacterial Agents(2014)89 cited
- → Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate(2015)73 cited
- → The Phosphatidyl- myo -Inositol Mannosyltransferase PimA Is Essential for Mycobacterium tuberculosis Growth In Vitro and In Vivo(2014)50 cited
- → Genetic and chemical validation identifies Mycobacterium tuberculosis topoisomerase I as an attractive anti-tubercular target(2015)49 cited
- → Diarylthiazole: An Antimycobacterial Scaffold Potentially Targeting PrrB-PrrA Two-Component System(2014)47 cited